Skip to content

Efficacy and cost-utility of eHealth application 'Oncokompas' for patients with incurable cancer.

Efficacy and cost-utility of eHealth application 'Oncokompas' for patients with incurable cancer. - Effect evaluation of online application Oncokompas

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON48895
Enrollment
136
Registered
2018-09-13
Start date
2019-01-03
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oncologische aandoeningen cancer malignancies

Interventions

The intervention investigated in this study is the online self-management application Oncokompas. Oncokompas is an integrated eHealth self-management application to monitor the different domains of

Sponsors

Vrije Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria of the RCT: - Incurable cancer; no curative treatment options; - A prognosis of at least 3 months; - Awareness of the incurability of the cancer. Additional criteria of the PAMQOL-study: For the qualitative study additional inclusion criteria are that a patient must have completed the RCT and gave his/her permission on the informed consent form of the RCT that he/she could be approached for the follow-up study.

Exclusion criteria

Exclusion criteria: - Not having access to the internet and not having an e-mail address; - Severe cognitive impairments; - Psychotic behaviour (delusions and hallucinations); - Poor understanding of the Dutch language (and thereby not able to complete a Dutch questionnaire); - Younger than 18 years; - Patients too ill to participate; - Not willing to participate; - No informed consent; - Patients who participated in the randomized controlled trial of the ICT4CANCER project (as a cancer survivor), but who are now diagnosed with incurable cancer; - E-mail address of patient is already registered in Oncokompas (this means that this patient is familiar with using Oncokompas); - Patients of which their physician/nurse thinks participation in another study will be too much of a burden.

Design outcomes

Primary

MeasureTime frame
The primary outcome measue is patient activation (PAM).

Secondary

MeasureTime frame
Secondary outcomes are general self-efficacy (GSE), quality of life (EORTC QLQ-C15-PAL). To investigate the cost-utility we will use different cost questionnaires (iMCQ and iPCQ) and the EQ-5D.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)